HEALTH CATALYST INC's ticker is HCAT and the CUSIP is 42225T107. A total of 202 filers reported holding HEALTH CATALYST INC in Q2 2021. The put-call ratio across all filers is 0.16 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $161,252 | -18.6% | 15,934 | +0.6% | 0.00% | – |
| Q2 2023 | $198,050 | +17.4% | 15,844 | +9.6% | 0.00% | – |
| Q1 2023 | $168,678 | +9.8% | 14,454 | 0.0% | 0.00% | – |
| Q4 2022 | $153,646 | +12.2% | 14,454 | +2.3% | 0.00% | – |
| Q3 2022 | $137,000 | -33.2% | 14,134 | 0.0% | 0.00% | – |
| Q2 2022 | $205,000 | -44.0% | 14,134 | +0.8% | 0.00% | -100.0% |
| Q1 2022 | $366,000 | -34.2% | 14,024 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $556,000 | -17.8% | 14,024 | +3.7% | 0.00% | 0.0% |
| Q3 2021 | $676,000 | -6.6% | 13,525 | +3.7% | 0.00% | 0.0% |
| Q2 2021 | $724,000 | +57.0% | 13,045 | +32.3% | 0.00% | 0.0% |
| Q1 2021 | $461,000 | +16.1% | 9,860 | +8.2% | 0.00% | 0.0% |
| Q4 2020 | $397,000 | +19.2% | 9,110 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $333,000 | +35.9% | 9,110 | +8.6% | 0.00% | 0.0% |
| Q2 2020 | $245,000 | – | 8,390 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Daventry Group, LP | 1,574,175 | $15,930,651 | 10.16% |
| First Light Asset Management, LLC | 2,930,144 | $29,653,057 | 2.82% |
| Nepsis Inc. | 905,804 | $9,166,736 | 2.81% |
| Granahan Investment Management | 1,177,903 | $11,920,378 | 0.42% |
| Rhenman & Partners Asset Management AB | 320,000 | $3,238,400 | 0.35% |
| Bares Capital Management | 700,000 | $7,084,000 | 0.30% |
| PIER 88 INVESTMENT PARTNERS LLC | 101,470 | $1,026,876 | 0.26% |
| Counterpoint Mutual Funds LLC | 24,086 | $243,750 | 0.20% |
| Brendel Financial Advisors LLC | 11,831 | $120 | 0.18% |
| CVS HEALTH Corp | 32,273 | $326,598 | 0.18% |